Development
D
SOPHiA GENETICS SA SOPH
$3.18 $0.03181.01% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income -78.98M -68.89M -78.38M -81.66M -87.45M
Total Depreciation and Amortization 5.51M 5.40M 4.89M 4.49M 3.79M
Total Amortization of Deferred Charges 2.83M 2.51M 2.26M 1.78M 1.78M
Total Other Non-Cash Items 21.20M 17.15M 15.60M 13.62M 13.06M
Change in Net Operating Assets 872.00K -3.78M -2.63M -5.71M -1.27M
Cash from Operations -48.58M -47.61M -58.26M -67.48M -70.09M
Capital Expenditure -1.49M -3.29M -4.08M -4.04M -4.10M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 9.81M 26.00M 32.02M 51.79M 46.07M
Cash from Investing 8.32M 22.71M 27.94M 47.75M 41.97M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -3.04M -3.10M -3.14M -2.93M -2.32M
Issuance of Common Stock 226.00K 207.00K 207.00K 851.00K 759.00K
Repurchase of Common Stock -- -- -11.00K -11.00K -11.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -2.82M -2.89M -2.94M -2.09M -1.57M
Foreign Exchange rate Adjustments 5.02M 2.74M 2.92M -321.00K -1.97M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -38.05M -25.06M -30.35M -22.15M -31.66M